Matches in Nanopublications for { ?s ?p "[The gene-gene interaction analyses demonstrated that individuals with combined GSTT1 null and NAT2 slow acetylators had an additional increased risk of gastric cancer, with an OR of 3.00 (95%CI: 1.52-5.93) and an AP of 52%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP499581.RAWslRhEuhAIyw2KNGFPdo5UvinQdbMyGVPFsdB9_bi54130_assertion description "[The gene-gene interaction analyses demonstrated that individuals with combined GSTT1 null and NAT2 slow acetylators had an additional increased risk of gastric cancer, with an OR of 3.00 (95%CI: 1.52-5.93) and an AP of 52%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499581.RAWslRhEuhAIyw2KNGFPdo5UvinQdbMyGVPFsdB9_bi54130_provenance.
- NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_assertion description "[The gene-gene interaction analyses demonstrated that individuals with combined GSTT1 null and NAT2 slow acetylators had an additional increased risk of gastric cancer, with an OR of 3.00 (95%CI: 1.52-5.93) and an AP of 52%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_provenance.
- NP416960.RAp-dao3PRGu6B6F0CfO6K_JZ1yBNIUvtvaOoAUxHe70g130_assertion description "[The gene-gene interaction analyses demonstrated that individuals with combined GSTT1 null and NAT2 slow acetylators had an additional increased risk of gastric cancer, with an OR of 3.00 (95%CI: 1.52-5.93) and an AP of 52%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416960.RAp-dao3PRGu6B6F0CfO6K_JZ1yBNIUvtvaOoAUxHe70g130_provenance.